ASP Isotopes (ASPI) Accused of Deceiving Investors with Bogus Nuclear Tech Claims – Hagens Berman

Core Viewpoint - ASP Isotopes Inc. is facing a securities class action lawsuit for allegedly misleading investors regarding its nuclear fuel technologies, specifically its Aerodynamic Separation Process and Quantum Enrichment technologies [1][2][3]. Group 1: Allegations and Lawsuit Details - The lawsuit claims that ASP Isotopes overstated the effectiveness of its enrichment technologies and the development potential of its high assay low-enriched uranium facility [3]. - A report by Fuzzy Panda Research, released on November 26, 2024, indicated that ASP Isotopes' technology is outdated and unlikely to be commercially viable, which led to the revelation of the alleged misleading statements [3][4]. - Following the report, ASP Isotopes' stock price dropped by 23% in a single trading day, reflecting the market's reaction to the negative information [5]. Group 2: Investigation and Response - Hagens Berman, a shareholder rights firm, has initiated an investigation into whether ASP Isotopes misled investors about the commercial prospects of its technologies [6]. - The firm is encouraging investors who suffered losses to submit their claims and is also seeking whistleblowers with non-public information regarding ASP Isotopes [6][7].